| To: | GlaxoSmithKline Biologicals S.A. (pamela.a.may@gsk.com) |
| Subject: | TRADEMARK APPLICATION NO. 78188524 - HIBERIX - TMB30096 |
| Sent: | 5/12/03 12:47:22 PM |
| Sent As: | ECom116 |
| Attachments: |
UNITED STATES PATENT AND TRADEMARK OFFICE
|
SERIAL NO: 78/188524
APPLICANT: GlaxoSmithKline Biologicals S.A.
|
|
|
CORRESPONDENT ADDRESS: PAMELA A. MAY GlaxoSmithKline 709 Swedeland Road UW2221 King of Prussia PA USA 19406-0939
|
RETURN ADDRESS: Commissioner for Trademarks 2900 Crystal Drive Arlington, VA 22202-3514 ecom116@uspto.gov
If no fees are enclosed, the address should include the words "Box Responses - No Fee." |
|
MARK: HIBERIX
|
|
|
CORRESPONDENT’S REFERENCE/DOCKET NO: TMB30096
CORRESPONDENT EMAIL ADDRESS: pamela.a.may@gsk.com |
Please provide in all correspondence:
1. Filing date, serial number, mark and applicant's name. 2. Date of this Office Action. 3. Examining Attorney's name and Law Office number. 4. Your telephone number and e-mail address.
|
Serial Number 78/188524
NOTICE OF SUSPENSION
Action on this application is suspended pending receipt of a true copy, a photocopy, a certification, or a certified copy of a foreign registration from the applicant's country of origin. If the registration is in a foreign language, an English translation must be submitted. The true copy, photocopy, certification, or certified copy of the registration should be forwarded to the Examining Attorney as soon as possible. If the foreign application is abandoned, the Examining Attorney should be advised.
/Zhaleh Sybil Delaney/
Trademark Attorney
Law Office 116
(703) 306-7908
ecom116@USPTO.gov